Position in CGEN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,409
-$67 QoQ
Shares Held
2,070
-29.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in CGEN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,409 | 2,070 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $4,476 | 2,926 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,262 | 1,539 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $2,395 | 1,346 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $6,848 | 4,691 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $18,514 | 12,101 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $122,147 | 67,485 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $303,696 | 180,772 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $183,520 | 71,132 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $44,934 | 22,694 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $5 | 6 | Shares | Defined | 2023-11-14 | |
| 2022-09-30 | $139,465 | 211,311 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $298,562 | 161,385 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $956,694 | 297,110 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $716,147 | 166,546 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,073,579 | 179,829 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,727,357 | 208,618 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $2,219,861 | 258,424 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $703,783 | 58,116 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $1,906,385 | 117,316 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,854,293 | 123,455 | Shares | Defined | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||